AAAAAA

   
Results: 1-15 |
Results: 15
MODEL OF COMPLICATIONS OF NIDDM .1. MODEL CONSTRUCTION AND ASSUMPTIONS
Authors: EASTMAN RC JAVITT JC HERMAN WH DASBACH EJ ZBROZEK AS DONG F MANNINEN D GARFIELD SA COPLEYMERRIMAN C MAIER W EASTMAN JF KOTSANOS J COWIE CC HARRIS M
Citation: Rc. Eastman et al., MODEL OF COMPLICATIONS OF NIDDM .1. MODEL CONSTRUCTION AND ASSUMPTIONS, Diabetes care, 20(5), 1997, pp. 725-734
MODEL OF COMPLICATIONS OF NIDDM .2. ANALYSIS OF THE HEALTH BENEFITS AND COST-EFFECTIVENESS OF TREATING NIDDM WITH THE GOAL OF NORMOGLYCEMIA
Authors: EASTMAN RC JAVITT JC HERMAN WH DASBACH EJ COPLEYMERRIMAN C MAIER W DONG F MANNINEN D ZBROZEK AS KOTSANOS J GARFIELD SA HARRIS M
Citation: Rc. Eastman et al., MODEL OF COMPLICATIONS OF NIDDM .2. ANALYSIS OF THE HEALTH BENEFITS AND COST-EFFECTIVENESS OF TREATING NIDDM WITH THE GOAL OF NORMOGLYCEMIA, Diabetes care, 20(5), 1997, pp. 735-744
CLARIFYING THE COSTS OF THEOPHYLLINE TOXICITY
Authors: ZBROZEK AS
Citation: As. Zbrozek, CLARIFYING THE COSTS OF THEOPHYLLINE TOXICITY, PharmacoEconomics, 6(5), 1994, pp. 485-485
EPISODE-FREE DAYS AS END-POINTS IN ECONOMIC EVALUATIONS OF ASTHMA THERAPY
Authors: ZBROZEK AS
Citation: As. Zbrozek, EPISODE-FREE DAYS AS END-POINTS IN ECONOMIC EVALUATIONS OF ASTHMA THERAPY, PharmacoEconomics, 5(1), 1994, pp. 78-78
CONTRAST-MEDIA COST-ANALYSIS .1.
Authors: ZBROZEK AS
Citation: As. Zbrozek, CONTRAST-MEDIA COST-ANALYSIS .1., Journal of the American College of Cardiology, 23(3), 1994, pp. 826-826
DO GENERIC HEALTH MEASURES HAVE A ROLE IN THE ASSESSMENT OF RA
Authors: ZBROZEK AS
Citation: As. Zbrozek, DO GENERIC HEALTH MEASURES HAVE A ROLE IN THE ASSESSMENT OF RA, Journal of rheumatology, 21(3), 1994, pp. 577-577
THE COST OF CYTOMEGALOVIRUS DISEASE IN RENAL-TRANSPLANTATION
Authors: ZBROZEK AS
Citation: As. Zbrozek, THE COST OF CYTOMEGALOVIRUS DISEASE IN RENAL-TRANSPLANTATION, Transplantation, 57(1), 1994, pp. 165-165
RIFABUTIN PROPHYLAXIS AGAINST MYCOBACTERIUM-AVIUM COMPLEX INFECTION
Authors: ZBROZEK AS
Citation: As. Zbrozek, RIFABUTIN PROPHYLAXIS AGAINST MYCOBACTERIUM-AVIUM COMPLEX INFECTION, The New England journal of medicine, 330(6), 1994, pp. 437-437
REEXAMINATION OF CLINICAL ASPECTS OF PHARMACOECONOMIC ANALYSIS
Authors: ZBROZEK AS CANTOR SB HILL DP
Citation: As. Zbrozek et al., REEXAMINATION OF CLINICAL ASPECTS OF PHARMACOECONOMIC ANALYSIS, American journal of hospital pharmacy, 51(23), 1994, pp. 2972-2973
PHARMACEUTICAL CARE AND INPATIENT OUTCOMES
Authors: ZBROZEK AS
Citation: As. Zbrozek, PHARMACEUTICAL CARE AND INPATIENT OUTCOMES, American journal of hospital pharmacy, 51(2), 1994, pp. 240-241
PHARMACOECONOMIC ANALYSIS OF ONDANSETRON VERSUS METOCLOPRAMIDE FOR CISPLATIN-INDUCED NAUSEA AND VOMITING
Authors: ZBROZEK AS CANTOR SB CARDENAS MP HILL DP
Citation: As. Zbrozek et al., PHARMACOECONOMIC ANALYSIS OF ONDANSETRON VERSUS METOCLOPRAMIDE FOR CISPLATIN-INDUCED NAUSEA AND VOMITING, American journal of hospital pharmacy, 51(12), 1994, pp. 1555-1563
COST-EFFECTIVENESS, NOT COST-CONTAINMENT
Authors: ZBROZEK AS
Citation: As. Zbrozek, COST-EFFECTIVENESS, NOT COST-CONTAINMENT, American journal of hospital pharmacy, 51(12), 1994, pp. 1569-1571
ANALYZE COSTS IN ADDITION TO ETHICS
Authors: ZBROZEK AS
Citation: As. Zbrozek, ANALYZE COSTS IN ADDITION TO ETHICS, American journal of hospital pharmacy, 51(1), 1994, pp. 125-126
THE VALIDITY AND REPRODUCIBILITY OF A WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT INSTRUMENT
Authors: REILLY MC ZBROZEK AS DUKES EM
Citation: Mc. Reilly et al., THE VALIDITY AND REPRODUCIBILITY OF A WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT INSTRUMENT, PharmacoEconomics, 4(5), 1993, pp. 353-365
EFFECTIVENESS AND COSTS OF DIGOXIN TREATMENT FOR ATRIAL-FIBRILLATION AND FLUTTER
Authors: ROBERTS SA DIAZ C NOLAN PE SALERNO DM STAPCZYNSKI JS ZBROZEK AS RITZ EG BAUMAN JL VLASSES PH
Citation: Sa. Roberts et al., EFFECTIVENESS AND COSTS OF DIGOXIN TREATMENT FOR ATRIAL-FIBRILLATION AND FLUTTER, The American journal of cardiology, 72(7), 1993, pp. 567-573
Risultati: 1-15 |